Impact of the use of procalcitonin assay in hospitalized adult patients with pneumonia at a community acute care hospital

Infection Control and Hospital Epidemiology

Volumn 33, Issue 4, 2012, Pages 424-426

  Kook, Janet L ^a   Chao, Stephanie R ^a   Le, Jennifer ^b   Robinson, Philip A ^a  

^a HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; COMMUNITY CARE; COMMUNITY HOSPITAL; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PNEUMONIA; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; TREATMENT DURATION;

AGED; ANTI-BACTERIAL AGENTS; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALS, COMMUNITY; HUMANS; MALE; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES;

EID: 84858854115     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/664764     Document Type: Article

References (7)

1. Shiley KT, Lautenbach E, Lee I. The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics? Infect Control Hosp Epidemiol 2010;31:1177-1183.
2. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402.
3. Müller B, Becker KL, Schadinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28:977-983
4. Meisner M. Procalcitonin: experience with a new diagnostic tool for bacterial infection and systemic inflammation. J Lab Med 1999;23:263-272.
5. Schuetz P, Christ-Crain M, Wolbers M, et al. Effect of procalcitonin- based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP Randomized Controlled Trial. JAMA 2009;302:1059-1066.
6. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin- guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, singleblinded intervention trial. Lancet 2004;363:600-607.
7. Procalcitonin reference ranges/interpretation of results. Thermo Scientific. Available at: http://www.procalcitonin.com/default.aspx?treep_3_4&keypproduct_lrti_reference_values. Accessed February 10, 2010.